Clinical Trials

Showing trials with last updates posted in 2017.

NCT01178944 | COMPLETED | PHASE2
35 participants

Pralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gastroesophageal Junction Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2017-12-13
Start Date:
2010-09-30
Completion:
2015-01-31
Conditions
  • Adenocarcinoma of the Gastroesophageal Junction
  • Esophageal Undifferentiated Carcinoma
  • Gastric Adenocarcinoma
  • Gastric Squamous Cell Carcinoma
  • Recurrent Esophageal Adenocarcinoma
  • Recurrent Esophageal Squamous Cell Carcinoma
  • Recurrent Gastric Carcinoma
  • Stage IIIB Esophageal Adenocarcinoma
  • Stage IIIB Esophageal Squamous Cell Carcinoma
  • Stage IIIB Gastric Cancer
  • Stage IIIC Esophageal Adenocarcinoma
  • Stage IIIC Esophageal Squamous Cell Carcinoma
  • Stage IIIC Gastric Cancer
  • Stage IV Esophageal Adenocarcinoma
  • Stage IV Esophageal Squamous Cell Carcinoma
  • Stage IV Gastric Cancer
  • Undifferentiated Gastric Carcinoma
Interventions
  • OTHER
  • DRUG
Previous
Sorted by latest updates
Next
Showing 40 trials per page